ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

June 6, 1986

In Brief: UK Scientist Receives Pezcoller Award; Yale Appoints Associate Director for Trials

January 19, 1996

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

ACCC Established FCCC Special Interest Group

April 11, 1986

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002

Center Studies Prevention For Endometrial Cancer

February 25, 2005